Regulations.gov document
Draft Guidance for Industry on Liposome Drug Products: Chemistry, Manufacturing, and…
Notice · FDA-2002-D-0093 · posted Aug 28, 2002
Key facts
| Document ID | FDA-2002-D-0093-0001 |
|---|---|
| Title | Draft Guidance for Industry on Liposome Drug Products: Chemistry, Manufacturing, and Controls; Human Pharmacokinetics and Bioavailability; and Labeling Documentation; Availability |
| Document type | Notice |
| Subtype | Notice of Availability |
| Agency | FDA |
| Docket | FDA-2002-D-0093 |
| Posted | Aug 28, 2002 |
| Comment period opens | Aug 28, 2002 |
| Comments due | Nov 20, 2002 |
| Effective date | Aug 13, 2002 |
At a glance
- 1–9 Pages
- No Open for comment
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: